phrykt

Gilead Sciences (GILD) share buybacks: $1.9B

Gilead Sciences spent $1.9B buying back its own shares in the year ended Dec 31, 2025, up 67.1% from $1.1B a year earlier.

From Gilead Sciences's filings with the SEC · Read the filing · GILD stock page

Gilead Sciences share buybacks by year

$546M2021$1.4B2022$1B2023$1.1B2024$1.9B2025

#118 of 1,890 US companies by share buybacks · See the full ranking

Year endedShare buybacksChange
Dec 31, 2025$1.9B+67%
Dec 31, 2024$1.1B+15%
Dec 31, 2023$1B-28%
Dec 31, 2022$1.4B+156%
Dec 31, 2021$546M–

Share buybacks of similar companies

Companies in the same industry as Gilead Sciences, by SEC industry code, with the closest share buybacks. Each name opens the same page for that company.

CompanyShare buybacks, latest yearYear ended
Gilead Sciences$1.9BDec 31, 2025
Exelixis$948MJan 2, 2026
Halozyme Therapeutics$342MDec 31, 2025
Qiagen$280MDec 31, 2025
Neurocrine Biosciences$168MDec 31, 2025
BIO-TECHNE$41.7MJun 30, 2026
ADMA Biologics$31.9MDec 31, 2025

Questions and answers

What is Gilead Sciences's share buybacks?

Gilead Sciences spent $1.9B buying back its own shares in the year ended Dec 31, 2025, up 67.1% from $1.1B a year earlier.

Numbers as reported in Gilead Sciences's annual and quarterly reports to the SEC (XBRL data). A year is the company's fiscal year that falls mostly in that calendar year; balances such as cash and debt are as of the date shown. Data only, not investment advice. Methodology